Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections
<b>Background:</b> Carbapenems are one of the mainstays of treatment for antibiotic-resistant bacteria (ARB). This has made the rise of carbapenem-resistant bacteria a threat to global health. In fact, the World Health Organization (WHO) has identified carbapenem-resistant bacteria as critical pathogens, and the development of novel antibacterials capable of combating infections caused by these bacteria is a priority. <b>Objective</b>: With the aim of finding new alternatives to fight against ARB and especially against carbapenem-resistant bacteria, we have developed a series of living materials formed by incorporating the probiotics <i>Lactobacillus plantarum</i> (<i>Lp</i>), <i>Lactobacillus fermentum</i> (<i>Lf</i>), and a mixture of both (<i>L. plantarum</i>+<i>L. fermentum</i>) into bacterial cellulose (BC). <b>Results</b>: These probiotic-loaded bacterial celluloses inhibited the proliferation of three ARB, including two carbapenem-resistant enterobacteria (CRE), identified as <i>Klebsiella pneumoniae</i> and <i>Enterobacter cloacae</i>, and a carbapenem-resistant <i>Pseudomonas aeruginosa</i>. Interestingly, while the probiotics <i>L. plantarum</i>, <i>L. fermentum</i>, and the mixture of both were found to be inactive against these ARB, they became active once incorporated into BC. <b>Conclusions</b>: The increase in activity is due to the known effect that cells increase their activity once incorporated into a suitable matrix, forming a living material. For the same reasons, the probiotics in the living materials BC-<i>L. plantarum</i>, BC-<i>L. fermentum</i>, and BC-<i>L. plantarum</i>+<i>L. fermentum</i> showed increased stability, allowing them to be stored with bacterial activity for long periods of time (two months).
Authors
- José Gutiérrez Fernández (ORCID: https://orcid.org/0000-0001-6146-9740)
- José Manuel Delgado‐López (ORCID: https://orcid.org/0000-0001-9643-9322)
- José M. Domínguez‐Vera (ORCID: https://orcid.org/0000-0002-1639-744X)
- Víctor Garcés (ORCID: https://orcid.org/0000-0003-2441-7436)
- Pablo Alarcón‐Guijo (ORCID: https://orcid.org/0000-0001-6243-7708)
- Laura Cerezo‐Collado (ORCID: https://orcid.org/0009-0007-9872-841X)
Institutions
- Universidad de Granada (ES)
- Hospital Universitario Virgen de las Nieves (ES)
Publication Details
- Journal
- Antibiotics
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3390/antibiotics13111003
- Citations
- 4
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- European Commission
- Agencia Estatal de Investigación